-
Condition:
-
Country of Origin: USA
-
Warranty:
- Weight: 31.65 lb
- Sterile
- Nonpyrogenic solution
- Comes in an EXCEL IV container
- Not made with natural rubber latex, PCV, or DEHP
-
Learn more:
-
Purchasing Restriction: Medical license or prescription required
-
MFR:
B. Braun
Ships from MFI Medical
-
MPN: P8721
- Phone: (800) 227-2862
+ Free Shipping
Frequently asked questions
Is the EXCEL IV container free of latex and PVC?
Yes, the B. Braun Heparin Sodium Injections utilize the proprietary EXCEL IV container system, which is manufactured to high safety standards and is free from common materials often avoided in clinical settings.
Specifically, these containers are manufactured without:
- Natural Rubber Latex
- Polyvinyl Chloride (PVC)
- Di(2-ethylhexyl) phthalate (DEHP)
This deliberate exclusion of materials helps ensure high compatibility while maintaining the sterile and nonpyrogenic nature of the heparin sodium solution for reliable intravenous administration.
Are B. Braun Heparin Sodium Injections safe for patients with latex allergies?
Yes, the EXCEL IV container used for B. Braun Heparin Sodium Injections is not made with natural rubber latex, making it safe for patients with latex allergies.
What volumes and concentrations are offered?
These Heparin Sodium Injections are offered in various configurations to meet precise clinical requirements, all packaged in the modern B. Braun EXCEL IV container system.
You can choose from the following dimensions and formulations:
- Container Volumes: 250 mL and 500 mL.
- Base Solutions (Diluents):
- 0.9% Sodium Chloride Injection
- 5% Dextrose Injection
- Potency and Concentration Options: The total units and concentration per milliliter vary to provide dosage flexibility:
- 1,000 Units total (2 Units/mL)
- 20,000 Units total (40 Units/mL)
- 25,000 Units total (50 Units/mL or 100 Units/mL)
Is the EXCEL IV container free from concerning materials?
Yes, B. Braun Heparin Sodium Injections are supplied in the proprietary EXCEL IV container system, which is designed with enhanced patient safety in mind.
The container is certified to be free from several materials often associated with patient concerns:
- Natural Rubber Latex: Excluded to eliminate the risk of latex-related allergies.
- PVC (Polyvinyl Chloride): Not used in the container structure.
- DEHP (Di-2-ethylhexyl phthalate): Excluded to minimize leaching concerns.
This robust material exclusion ensures the sterile, nonpyrogenic solution is safe and highly compatible for intravenous administration.
How many individual units come in a case?
The B. Braun Heparin Sodium Injections are packaged for clinical use. Each case contains 24 individual units of the chosen configuration.
These units are provided in the specialized EXCEL IV container system, ready for intravenous administration.
What diluent solutions are available?
The B. Braun Heparin Sodium Injections are supplied with two primary diluent options, allowing for flexibility in clinical application:
- 0.9% Sodium Chloride Injection
- 5% Dextrose Injection
These sterile and nonpyrogenic solutions are packaged in the specialized EXCEL IV container system. The concentrations of Heparin Sodium vary widely across configurations, ranging from 1,000 Units up to 25,000 Units.
What is the source of the heparin sodium used in these injections?
The heparin sodium in B. Braun Heparin Sodium Injections is derived from porcine intestinal mucosa.
How are B. Braun Heparin Sodium Injections administered?
B. Braun Heparin Sodium Injections are administered via intravenous injection.
Are the injections safely nonpyrogenic?
Yes, these B. Braun Heparin Sodium Injections are guaranteed to be both sterile and nonpyrogenic. This high standard is essential for products administered intravenously, ensuring the solution is free from contaminants and fever-inducing substances for patient safety.
How is the high-quality Heparin potency determined?
The potency of B. Braun Heparin Sodium Injections is rigorously determined and standardized to guarantee reliable anticoagulant activity.This standardization process involves:* Method: Potency is quantified using a biological assay.* Measurement: The assay precisely measures the units of heparin activity per milligram of the substance.* Standardization: This activity is strictly benchmarked against a USP reference standard (United States Pharmacopeia) for maximum consistency and quality control.